Elizabeth Curtin, Author at Yseop

The FDA Is Now Using Generative AI to Review Submissions. Here’s What That Means for Pharma Teams

The FDA has begun using generative AI to review drug submissions, signaling a major shift in regulatory review. Learn how this impacts pharma teams and what it takes to make your content AI-ready.

The FDA Is Now Using Generative AI to Review Submissions. Here’s What That Means for Pharma Teams Read More »

AI is transforming biopharma in 2025—from faster drug discovery to personalized medicine. Explore the innovations reshaping healthcare's future.

Whitepaper: Harness the Power of Generative AI in Pharma

Whitepapers / By Elizabeth Curtin

Download Yseop’s Comprehensive Guide to Workflow Automation The pharmaceutical industry is undergoing one of the most significant transformations in history with the introduction of Generative AI. Discover how the world’s largest pharmaceutical firms have accelerated drug development and significantly reduced time to market throughout the clinical trial process using AI in our latest whitepaper.

Whitepaper: Harness the Power of Generative AI in Pharma Read More »

Cognizant and Yseop announce plan to partner to scale medical writing through Generative AI

News & Press Releases / By Elizabeth Curtin

Cognizant’s AI and industry expertise, combined with Yseop’s generative AI platform, aims to improve the productivity of scientific writers across the life sciences value chain

Cognizant and Yseop announce plan to partner to scale medical writing through Generative AI Read More »

With Support from AWS, Yseop Develops a Unique Generative AI Application for Regulatory Document Generation Across BioPharma

News & Press Releases / By Elizabeth Curtin

Already a leading provider of Generative AI for life sciences, Yseop leverages AWS for greater scalability and the acceleration of new drug introductions

With Support from AWS, Yseop Develops a Unique Generative AI Application for Regulatory Document Generation Across BioPharma Read More »

Yseop Copilot vs. Alternative GenAI Technologies

Blog / By Elizabeth Curtin

See how Yseop Copilot is different from other Generative AI technologies across BioPharma and regulated industries.

Yseop Copilot vs. Alternative GenAI Technologies Read More »

The Promise And Challenge Of Deploying AI In Clinical Trials

News & Press Releases / By Elizabeth Curtin

Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.

The Promise And Challenge Of Deploying AI In Clinical Trials Read More »

Yseop Announces Strategic Investment and Celebrates Milestone of 150 Clinical Trials Powered by Generative AI

News & Press Releases / By Elizabeth Curtin

Yseop Announces Strategic Investment and Celebrates Milestone of 150 Clinical Trials Powered by Generative AI Read More »

AI uncovered podcast with Gregor Mittersinker.

AI Uncovered with Gregor Mittersinker (ChatGPT & the Impact on UX and Design)

Podcast / By Elizabeth Curtin

Listen to the next episode of AI Uncovered with Gregor Mittersinker.

AI Uncovered with Gregor Mittersinker (ChatGPT & the Impact on UX and Design) Read More »

Yseop Launches “Yseop Copilot,” the World’s Most Secure Digital Colleague for Scientific Writers

News & Press Releases / By Elizabeth Curtin

Reimagining the future of scientific writing, Yseop Copilot leverages pre-trained cutting edge Generative AI models (LLMs) for the BioPharma industry.

Yseop Launches “Yseop Copilot,” the World’s Most Secure Digital Colleague for Scientific Writers Read More »

AI Uncovered with Marjo Gazak (Generate Clinical Drafts in Seconds)

Podcast / By Elizabeth Curtin

Listen to the next episode of AI Uncovered with Marjo Gazak.

AI Uncovered with Marjo Gazak (Generate Clinical Drafts in Seconds) Read More »